Concentration: 1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4
mRNA length: 1474 nucleotides.
MW MRNA52= 475220 g/mol; MRNA53= 483860 g/mol; MRNA54= 479540 g/mol.
N SARS-Cov-2 mRNA has been designed to produce high expression level of the nucleocapsid protein of SARS-CoV-2 virus.
OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
N SARS-Cov-2 mRNAs:
-
#MRNA52 does not bear any additional nucleotide modifications.
-
#MRNA53 is modified with 5-methoxyuridine (5moU) to reduce innate immune response.
-
#MRNA54 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response.
Size: 20 µg, 100µg or 1 mg.
Storage: -80°C
mRNAs ARE SHIPPED WITH DRY ICE
CATALOG NUMBER |
UNIT SIZE |
MRNA52-20 |
Unmodified N SARS-Cov-2 mRNA 20 µg
|
MRNA52-100 |
Unmodified N SARS-Cov-2 mRNA 100 µg
|
MRNA52-1000 |
Unmodified N SARS-Cov-2 mRNA 1 mg
|
MRNA53-20 |
N SARS-Cov-2 mRNA (5moU) 20 µg
|
MRNA53-100 |
N SARS-Cov-2 mRNA (5moU) 100 µg
|
MRNA53-1000 |
N SARS-Cov-2 mRNA (5moU) 1 mg
|
MRNA54-20 |
N SARS-Cov-2 mRNA (N1-mψ) 20 µg
|
MRNA54-100 |
N SARS-Cov-2 mRNA (N1-mψ) 100 µg
|
MRNA54-1000 |
N SARS-Cov-2 mRNA (N1-mψ) 1 mg
|